SlideShare a Scribd company logo
HBV and HCV: America’s
Hidden Epidemics
Jeffrey Levi, PhD
Trust for America’s Health
October 14, 2010
Who We Are
 Trust for America’s Health (TFAH) is a
non-profit, non-partisan organization
dedicated to saving lives by protecting
the health of every community and
working to make disease prevention a
national priority.
Goals of the Report
 Follow-on to IOM report
 Concrete strategies for federal action
 Unique opportunities right now through
Affordable Care Act and scientific
breakthroughs
Overview of Problem
 There are a number of unique challenges that must
be addressed when combating the hepatitis B virus
(HBV) or hepatitis C virus (HCV), including:
 health complications that take decades to develop;
 significant social stigmas connected to the viruses;
 disproportionately impacts racial, ethnic and sexual
minorities; and
 infectious disease prevention strategies have traditionally
been siloed.
Key Findings
 Nearly two percent of the U.S. population may have
some form of the disease – and approximately five
million of these individuals will develop a chronic
form of the diseases.
 An estimated 65 to 75 percent of the five million
Americans currently infected with HBV or HCV do
not even know they have the virus.
Impacts on Diverse Populations
 Of the more than five million Americans with HBV
or HCV:
 Baby Boomers account for two-thirds of HCV cases - and
if left untreated, it could lead to a major increase in
upcoming Medicare spending;
 African Americans account for 22 percent of HCV cases;
 Asian and Pacific Islander Americans account for 50
percent of HBV cases; and
 Gay and bisexual men account for 15 percent to 25
percent of new HBV cases and are at increased risk for
HCV infection.
Once-in-a-Generation Opportunity
 New prevention options and
treatment possibilities due to
Patient Protection and
Affordable Care Act (ACA).
 Scientific breakthroughs will
make treatment, vaccination
easier.
Key Recommendations
 Tracking hepatitis to better target
prevention and treatment efforts:
 Build on existing HIV surveillance systems;
strengthen state and local networks
 Focus on tracking both cumulative cases and
emerging outbreaks
 Assure that emerging electronic health record
system collects appropriate hepatitis-related data
 Better tracking of new outbreaks
Key Recommendations
 HBV and HCV screening and HBV
vaccinations should be the standard of care
in the reformed health care system:
 Screen based on risk factors and age
 Make this part of initial Medicare visit and essential
health benefit under health reform
 Reach out to non-traditional settings
 HBV vaccination should be encouraged as part of
the preventive benefit under health reform and
monitored through electronic health records
Key Recommendations
 Improve treatment by ensuring everyone who is
diagnosed is linked to care and receives the
standard of care:
 Appropriate coverage and reimbursement for treatment
 Public-private treatment guidelines updated regularly
 Plans under Exchanges as well as Medicare and Medicaid
required to meet treatment guidelines and have networks
with qualified providers of hepatitis care
 Improve referral systems
 Expand access to wraparound services, perhaps through
Ryan White Program
Key Recommendations
 Assure adherence to treatment:
 Treatment requires a continuum from point of
screening throughout care
 Provide appropriate culturally and linguistically
sensitive support services
 Special consideration for marginalized
populations
Key Recommendations
 Prevent New Infections:
 Eliminate newborn HBV infections
 CMS-CDC joint initiative
 Eliminate health care-associated HBV and HCV
infections
 Promote universal HBV vaccination
 Bolster prevention campaigns and public awareness
Key Recommendations
 Strengthen research agenda:
 Single dose HBV vaccine; develop HCV vaccine;
simplify treatment options; rapid tests
 Funding proportionate to public health risk
 NIH funding for hepatitis research is ~$150 million
The cost of doing nothing
 150,000 Americans could die from liver
cancer or end-state liver disease (IOM)
 Medical costs for HCV patients could double
over the next 20 years from $30 billion to $80
billion (Milliman)
 Many of these costs will be borne by Medicare
and Medicaid
 A comprehensive approach that includes early
diagnosis and treatment can reverse this trend
Questions?
 Please contact:
 Dara Lieberman, Government Relations Manager
dlieberman@tfah.org, 202-223-9870 x. 20
 Visit TFAH online at www.healthyamericans.org

More Related Content

PPT
Presentation to the WA Joint Conference on Health 2010
PPT
Group D Team Presentation
PDF
Kwong_Willie Hepatitis B Policy Change Porject
PPT
Apha slides tfah hep b & c wang slides[1]
PDF
HCV and HIV Co-Infection among Adolescents and Young Adults in Massachusetts:...
DOCX
Better health for everyone health care in two worlds
PPTX
Investment in Primary Care, Michael Fine, MD - SLC 2015
PPTX
HIV/Aids Surveillance Systems: Are They Implemented Effectively?
Presentation to the WA Joint Conference on Health 2010
Group D Team Presentation
Kwong_Willie Hepatitis B Policy Change Porject
Apha slides tfah hep b & c wang slides[1]
HCV and HIV Co-Infection among Adolescents and Young Adults in Massachusetts:...
Better health for everyone health care in two worlds
Investment in Primary Care, Michael Fine, MD - SLC 2015
HIV/Aids Surveillance Systems: Are They Implemented Effectively?

What's hot (20)

PPT
WellPortals - Wellness That Makes Financial Sense
PDF
White Paper - Population Health
PPTX
Progress on the health related SDGs and targets in the Eastern Mediterranean ...
PDF
Documenting challenges for people living with hiv
PPTX
Leading Through Health Reform
PPT
Hospital Innovation Marketing Summit Final Sept 17 2015
PPTX
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
PPT
Dr jojo go hep b liver ca summit
PDF
Evolving healthcare delivery models
PPTX
Introduction to the annual report
PDF
Primary care of the hiv infected adult
PPT
90110 pp tx_ch02
PPTX
Who patient safety program
PPTX
NCDs in the Context of the SDGs
PDF
Partnerships on AMR and NCDs Mirfin Mpundu
PPTX
Ending the pandemic; preventing future health emergencies
PPTX
Supporting Staff During COVID-19
PPTX
Ensuring continuity of essential health services: A critical priority during ...
PDF
Community Health Centers: Making a Difference
PPTX
Global Health | Burden of Diseases | millennium goals of global health | Repo...
WellPortals - Wellness That Makes Financial Sense
White Paper - Population Health
Progress on the health related SDGs and targets in the Eastern Mediterranean ...
Documenting challenges for people living with hiv
Leading Through Health Reform
Hospital Innovation Marketing Summit Final Sept 17 2015
Behavioral Health Navigator Presentation by Emerson Evans 12-12-13
Dr jojo go hep b liver ca summit
Evolving healthcare delivery models
Introduction to the annual report
Primary care of the hiv infected adult
90110 pp tx_ch02
Who patient safety program
NCDs in the Context of the SDGs
Partnerships on AMR and NCDs Mirfin Mpundu
Ending the pandemic; preventing future health emergencies
Supporting Staff During COVID-19
Ensuring continuity of essential health services: A critical priority during ...
Community Health Centers: Making a Difference
Global Health | Burden of Diseases | millennium goals of global health | Repo...
Ad

Similar to Apha slides tfah hep b &c levi slides[1] (20)

PPT
Hapatitis overview
PDF
Viral hepatitis action plan
PPTX
HCV prevention Final Delta 2015.pptx
PDF
2019-cde-ias-hepatitis-c-elimination.pdf
PPTX
Khushi mawa on hep a b c d e and u..pptx
PPTX
DOC-20241213-WA0shhsjsnsjajbshs011..pptx
PPTX
Viral hepatitis A to E .
PPTX
HepTREC Marketing Plan
PDF
Tackling hepatitis C: Moving towards an integrated policy approach
PPTX
Hepatitis B
PPTX
Hepatitis day,2021
PDF
abctabljwiebsjwjjsbsywjwbshsuajajahahae.pdf
PPTX
Viral_Hepatitis_epidemiologyPresentation.pptx
PPT
Dr samuel so hep b liver ca summit
PDF
Understanding Hepatitis: Causes, Symptoms & Treatment Options
PPTX
Hepatitis-C-Overview_Final.pptx regarding hepatitc causes treatment
PDF
March 192015talkforresidents final03232015 (1)
PDF
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
PPTX
20201020_Action Plan ppt hepatitis (Eng).pptx
PPTX
Dr diana payawal hb liver ca summit
Hapatitis overview
Viral hepatitis action plan
HCV prevention Final Delta 2015.pptx
2019-cde-ias-hepatitis-c-elimination.pdf
Khushi mawa on hep a b c d e and u..pptx
DOC-20241213-WA0shhsjsnsjajbshs011..pptx
Viral hepatitis A to E .
HepTREC Marketing Plan
Tackling hepatitis C: Moving towards an integrated policy approach
Hepatitis B
Hepatitis day,2021
abctabljwiebsjwjjsbsywjwbshsuajajahahae.pdf
Viral_Hepatitis_epidemiologyPresentation.pptx
Dr samuel so hep b liver ca summit
Understanding Hepatitis: Causes, Symptoms & Treatment Options
Hepatitis-C-Overview_Final.pptx regarding hepatitc causes treatment
March 192015talkforresidents final03232015 (1)
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
20201020_Action Plan ppt hepatitis (Eng).pptx
Dr diana payawal hb liver ca summit
Ad

More from APHA Alcohol, Tobacco, & Other Drugs Section (13)

PDF
Atod program guide apha 2011
PDF
Samhsa aug 2010 addiction mh systembrief
PPT
Apha slides tfah hep b &c ninburg slides
PPT
Health reform and other policies around substance abuse treatment systems ond...
PPTX
Survey Analyses for Implementing an Electronic Information System to Enhance ...
PPT
Outcomes Measures for Sexual Minority Patients in an Opioid Treatment Program
PPT
Hepatitis B Virus and Hepatitis C Virus Services Offered by Substance Abuse T...
PPT
Implementation of an Electronic Information System to Enhance Practice at an ...
PPT
Implementation of an Electronic Information System to Enhance Practice at an ...
PPT
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...
PDF
YouTube: An Underutilized Method for Disseminating Quit Smoking Messages to Y...
PDF
Evaluation of Smokefree.gov: A National Web-Assisted Tobacco Intervention
PDF
Evaluating Voice, Indiana's Youth Led Movement Against Tobacco
Atod program guide apha 2011
Samhsa aug 2010 addiction mh systembrief
Apha slides tfah hep b &c ninburg slides
Health reform and other policies around substance abuse treatment systems ond...
Survey Analyses for Implementing an Electronic Information System to Enhance ...
Outcomes Measures for Sexual Minority Patients in an Opioid Treatment Program
Hepatitis B Virus and Hepatitis C Virus Services Offered by Substance Abuse T...
Implementation of an Electronic Information System to Enhance Practice at an ...
Implementation of an Electronic Information System to Enhance Practice at an ...
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...
YouTube: An Underutilized Method for Disseminating Quit Smoking Messages to Y...
Evaluation of Smokefree.gov: A National Web-Assisted Tobacco Intervention
Evaluating Voice, Indiana's Youth Led Movement Against Tobacco

Recently uploaded (20)

PPTX
Imaging of parasitic D. Case Discussions.pptx
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
LUNG ABSCESS - respiratory medicine - ppt
PPTX
post stroke aphasia rehabilitation physician
PPTX
ACID BASE management, base deficit correction
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Cardiovascular - antihypertensive medical backgrounds
PPT
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
Obstructive sleep apnea in orthodontics treatment
Imaging of parasitic D. Case Discussions.pptx
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
CME 2 Acute Chest Pain preentation for education
LUNG ABSCESS - respiratory medicine - ppt
post stroke aphasia rehabilitation physician
ACID BASE management, base deficit correction
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
neonatal infection(7392992y282939y5.pptx
Cardiovascular - antihypertensive medical backgrounds
Copy-Histopathology Practical by CMDA ESUTH CHAPTER(0) - Copy.ppt
MENTAL HEALTH - NOTES.ppt for nursing students
Copy of OB - Exam #2 Study Guide. pdf
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
surgery guide for USMLE step 2-part 1.pptx
Obstructive sleep apnea in orthodontics treatment

Apha slides tfah hep b &c levi slides[1]

  • 1. HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010
  • 2. Who We Are  Trust for America’s Health (TFAH) is a non-profit, non-partisan organization dedicated to saving lives by protecting the health of every community and working to make disease prevention a national priority.
  • 3. Goals of the Report  Follow-on to IOM report  Concrete strategies for federal action  Unique opportunities right now through Affordable Care Act and scientific breakthroughs
  • 4. Overview of Problem  There are a number of unique challenges that must be addressed when combating the hepatitis B virus (HBV) or hepatitis C virus (HCV), including:  health complications that take decades to develop;  significant social stigmas connected to the viruses;  disproportionately impacts racial, ethnic and sexual minorities; and  infectious disease prevention strategies have traditionally been siloed.
  • 5. Key Findings  Nearly two percent of the U.S. population may have some form of the disease – and approximately five million of these individuals will develop a chronic form of the diseases.  An estimated 65 to 75 percent of the five million Americans currently infected with HBV or HCV do not even know they have the virus.
  • 6. Impacts on Diverse Populations  Of the more than five million Americans with HBV or HCV:  Baby Boomers account for two-thirds of HCV cases - and if left untreated, it could lead to a major increase in upcoming Medicare spending;  African Americans account for 22 percent of HCV cases;  Asian and Pacific Islander Americans account for 50 percent of HBV cases; and  Gay and bisexual men account for 15 percent to 25 percent of new HBV cases and are at increased risk for HCV infection.
  • 7. Once-in-a-Generation Opportunity  New prevention options and treatment possibilities due to Patient Protection and Affordable Care Act (ACA).  Scientific breakthroughs will make treatment, vaccination easier.
  • 8. Key Recommendations  Tracking hepatitis to better target prevention and treatment efforts:  Build on existing HIV surveillance systems; strengthen state and local networks  Focus on tracking both cumulative cases and emerging outbreaks  Assure that emerging electronic health record system collects appropriate hepatitis-related data  Better tracking of new outbreaks
  • 9. Key Recommendations  HBV and HCV screening and HBV vaccinations should be the standard of care in the reformed health care system:  Screen based on risk factors and age  Make this part of initial Medicare visit and essential health benefit under health reform  Reach out to non-traditional settings  HBV vaccination should be encouraged as part of the preventive benefit under health reform and monitored through electronic health records
  • 10. Key Recommendations  Improve treatment by ensuring everyone who is diagnosed is linked to care and receives the standard of care:  Appropriate coverage and reimbursement for treatment  Public-private treatment guidelines updated regularly  Plans under Exchanges as well as Medicare and Medicaid required to meet treatment guidelines and have networks with qualified providers of hepatitis care  Improve referral systems  Expand access to wraparound services, perhaps through Ryan White Program
  • 11. Key Recommendations  Assure adherence to treatment:  Treatment requires a continuum from point of screening throughout care  Provide appropriate culturally and linguistically sensitive support services  Special consideration for marginalized populations
  • 12. Key Recommendations  Prevent New Infections:  Eliminate newborn HBV infections  CMS-CDC joint initiative  Eliminate health care-associated HBV and HCV infections  Promote universal HBV vaccination  Bolster prevention campaigns and public awareness
  • 13. Key Recommendations  Strengthen research agenda:  Single dose HBV vaccine; develop HCV vaccine; simplify treatment options; rapid tests  Funding proportionate to public health risk  NIH funding for hepatitis research is ~$150 million
  • 14. The cost of doing nothing  150,000 Americans could die from liver cancer or end-state liver disease (IOM)  Medical costs for HCV patients could double over the next 20 years from $30 billion to $80 billion (Milliman)  Many of these costs will be borne by Medicare and Medicaid  A comprehensive approach that includes early diagnosis and treatment can reverse this trend
  • 15. Questions?  Please contact:  Dara Lieberman, Government Relations Manager dlieberman@tfah.org, 202-223-9870 x. 20  Visit TFAH online at www.healthyamericans.org